Wockhardt has a total of 2234 patents globally, out of which 629 have been granted. Of these 2234 patents, more than 19% patents are active. India is where Wockhardt has filed the maximum number of patents, followed by United States of America and Europe (EPO). Parallelly, India seems to be the main focused R&D center of Wockhardt.
Wockhardt was founded in the year 1967 by Habil F. Khorakiwala. The firm is a global pharmaceutical and biotechnology company.
Do read about some of the most popular patents of Wockhardt which have been covered by us in this article and also you can find Wockhardt patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Wockhardt patent portfolio.
How many patents does the CEO of Wockhardt have?
The CEO, Murtaza Khorakiwala, has 6 patents.
How many patents does Wockhardt have?
Wockhardt has a total of 2234 patents globally. These patents belong to 1032 unique patent families. Out of 2234 patents, 431 patents are active.
How Many Patents did Wockhardt File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Wockhardt Applications Filed | Wockhardt Patents Granted |
| 2022 | 5 | 12 |
| 2021 | 4 | 33 |
| 2020 | 17 | 29 |
| 2019 | 16 | 39 |
| 2018 | 42 | 55 |
| 2017 | 127 | 76 |
| 2016 | 86 | 88 |
| 2015 | 268 | 77 |
| 2014 | 231 | 51 |
| 2013 | 242 | 29 |
| 2012 | 157 | 31 |
| 2011 | 119 | 17 |
Explore the top-performing drugs that dominate the Pharmaceutical Industry
| Patent Number | Company | Product | Brand | Revenue | Patent Expiry Date |
| US9174975 | Sumitomo Pharma | Lurasidone Hydrochloride | Latuda | $1.75B | Jun-26 |
| US7612199 | Alfasigma | Rifaximin | Xifaxan | $1.64B | Nov-24 |
| US7902206 | Alfasigma | Rifaximin | Xifaxan | $1.64B | Nov-24 |
| US8158644 | Alfasigma | Rifaximin | Xifaxan | $1.64B | Nov-24 |
| US7371727 | Ironwood Pharma | Linaclotide | Linzess | $1.00B | Mar-25 |
Want to know which drugs are making over $1 Billion annually?
How many Wockhardt patents are Alive/Dead?
Worldwide Patents
How Many Patents did Wockhardt File in Different Countries?
Countries in which Wockhardt Filed Patents
| Country | Patents |
| India | 850 |
| United States Of America | 204 |
| Europe | 170 |
| Japan | 76 |
| Australia | 73 |
| Canada | 68 |
| China | 65 |
| Korea (South) | 61 |
| Mexico | 60 |
| Brazil | 58 |
| South Africa | 49 |
| Germany | 49 |
| Russia | 46 |
| New Zealand | 38 |
| Spain | 29 |
| Austria | 19 |
| Poland | 11 |
| Portugal | 10 |
| United Kingdom | 8 |
| Denmark | 8 |
| Norway | 6 |
| Malaysia | 6 |
| France | 5 |
| Hungary | 5 |
| Singapore | 3 |
| Israel | 3 |
| Indonesia | 3 |
| Eurasia | 2 |
| Slovenia | 2 |
| Italy | 2 |
Where are Research Centres of Wockhardt Patents Located?
10 Best Wockhardt Patents
US20030049320A1 is the most popular patent in the Wockhardt portfolio. It has received 138 citations so far from companies like Evonik Corporation and Acura Pharmaceuticals.
Below is the list of 10 most cited patents of Wockhardt:
| Publication Number | Citation Count |
| US20030049320A1 | 138 |
| US20060134206A1 | 135 |
| US6555139B2 | 131 |
| WO2013030735A1 | 118 |
| WO2013038330A1 | 115 |
| WO2014033560A1 | 84 |
| WO2003050107A1 | 65 |
| WO2007129176A2 | 64 |
| US6878713B2 | 54 |
| US6514986B2 | 52 |
What are Wockhardt key innovation segments?
What Technologies are Covered by Wockhardt?
The chart below distributes patents filed by Wockhardt